A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients

被引：0
|
作者：
C Jin
Y Fan
Y Meng
C Shen
Y Wang
S Hu
C Cui
T Xu
W Yu
J Jin
机构：
[1] Peking University First Hospital,Department of Urology
[2] Institute of Urology,Department of Urology
[3] Peking University,undefined
[4] Urogenital Diseases (male) Molecular Diagnosis and Treatment Center,undefined
[5] National Research Center for Genitourinary Oncology,undefined
[6] Peking University People’s Hospital,undefined
[7] Beijing,undefined
[8] China,undefined
[9] Peking University Health Science Center,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：333 / 339
页数：6
相关论文
共 50 条
  • [1] A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients (vol 19, pg 333, 2016)
    Jin, C.
    Fan, Y.
    Meng, Y.
    Shen, C.
    Wang, Y.
    Hu, S.
    Cui, C.
    Xu, T.
    Yu, W.
    Jin, J.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (04) : 429 - 429
  • [2] Harms of Intermittent vs Continuous Androgen-Deprivation Therapy for Prostate Cancer
    Niraula, Saroj
    Tannock, Ian F.
    [J]. JAMA ONCOLOGY, 2016, 2 (04) : 461 - 462
  • [3] Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
    Wolff, Johannes M.
    Abrahamsson, Per-Anders
    Irani, Jacques
    da Silva, Fernando Calais
    [J]. BJU INTERNATIONAL, 2014, 114 (04) : 476 - 483
  • [4] The benefits of intermittent androgen-deprivation therapy
    Timur Mitin
    Jason A. Efstathiou
    William U. Shipley
    [J]. Nature Reviews Clinical Oncology, 2012, 9 : 672 - 673
  • [5] Timing of androgen-deprivation therapy in prostate cancer
    Del Priore, Giuseppe
    Hoffman, Steven
    [J]. LANCET ONCOLOGY, 2017, 18 (11): : E633 - E633
  • [6] Insomnia and androgen-deprivation therapy for prostate cancer
    Savard, J.
    Ivers, H.
    Simard, S.
    [J]. PSYCHO-ONCOLOGY, 2007, 16 (09) : S150 - S151
  • [7] Metabolic and cardiovascular risks of androgen-deprivation therapy for prostate cancer
    Nambudiri, Vinod E.
    Keating, Nancy L.
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (04) : 531 - 537
  • [8] Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer
    Gupta, Dipti
    Chuy, Katherine Lee
    Yang, Ji Can
    Bates, Megan
    Lombardo, Marissa
    Steingart, Richard M.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (10) : 580 - +
  • [9] UROLOGICAL CANCER The benefits of intermittent androgen-deprivation therapy
    Mitin, Timur
    Efstathiou, Jason A.
    Shipley, William U.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (12) : 672 - 673
  • [10] METABOLIC SYNDROME IN PATIENTS WITH PROSTATE CANCER UNDERGOING INTERMITTENT ANDROGEN-DEPRIVATION THERAPY
    Rezaei, Mohammadali Mohammadzadeh
    Ghoreifi, Alireza
    Rezaei, Mohammadhadi Mohammadzadeh
    Kerigh, Behzad Feyzzadeh
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E770 - E770
12345